Alivus Life Sciences Ltd.

The sales declined to Rs. 5365.97 millions for the March 2024 quarter as compared to Rs. 6213.20 millions during the corresponding quarter last year.The Company to register a -33.08%  fall in the net profit for the quarter ended March 2024.The company reported a degrowth in operating Profit to 1445.77 millions from 2092.66 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202403	202303	% Var	202403	202303	% Var	202403	202303	% Var
Sales	5365.97	6213.20	-13.64	22832.14	21612.20	5.64	22832.14	21612.20	5.64
Other Income	31.31	28.36	10.40	120.42	289.57	-58.41	120.42	289.57	-58.41
PBIDT	1445.77	2092.66	-30.91	6862.88	6712.50	2.24	6862.88	6712.50	2.24
Interest	3.64	1.19	205.88	15.46	5.47	182.63	15.46	5.47	182.63
PBDT	1442.13	2091.47	-31.05	6847.42	6707.03	2.09	6847.42	6707.03	2.09
Depreciation	145.34	115.17	26.20	534.52	420.94	26.98	534.52	420.94	26.98
PBT	1296.79	1976.30	-34.38	6312.90	6286.09	0.43	6312.90	6286.09	0.43
TAX	317.42	512.73	-38.09	1604.02	1616.48	-0.77	1604.02	1616.48	-0.77
Deferred Tax	6.88	39.62	-82.64	81.88	110.37	-25.81	81.88	110.37	-25.81
PAT	979.37	1463.57	-33.08	4708.88	4669.61	0.84	4708.88	4669.61	0.84
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	26.94	33.68	-20.00	30.06	31.06	-3.22	30.06	31.06	-3.22